Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Gubra

Market Cap: DKK 6.5b

A biotech company, focuses on the pre-clinical contract research and peptide-based drug discovery within metabolic and fibrotic diseases in Europe, North America, and internationally.

Genmab

Market Cap: DKK 114.0b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Bavarian Nordic

Market Cap: DKK 17.9b

Develops, manufactures, and supplies life-saving vaccines.

ALK-Abelló

Market Cap: DKK 44.9b

Operates as an allergy solutions company in Europe, North America, and internationally.

Strategic Partners

Market Cap: DKK 36.8m

Does not have significant operations.

Zealand Pharma

Market Cap: DKK 31.7b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.

ChemoMetec

Market Cap: DKK 10.8b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

H. Lundbeck

Market Cap: DKK 43.1b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

BioPorto

Market Cap: DKK 586.5m

An in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the onset of disease states for management and therapies in Europe, North America, Asia, and internationally.